KR102427124B1 - 구충성 뎁시펩티드 화합물 - Google Patents

구충성 뎁시펩티드 화합물 Download PDF

Info

Publication number
KR102427124B1
KR102427124B1 KR1020187021726A KR20187021726A KR102427124B1 KR 102427124 B1 KR102427124 B1 KR 102427124B1 KR 1020187021726 A KR1020187021726 A KR 1020187021726A KR 20187021726 A KR20187021726 A KR 20187021726A KR 102427124 B1 KR102427124 B1 KR 102427124B1
Authority
KR
South Korea
Prior art keywords
independently
substituted
alkyl
halogen
pharmaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020187021726A
Other languages
English (en)
Korean (ko)
Other versions
KR20180100349A (ko
Inventor
이르 드 팔루아 루아끄 르
그레고리 파코프스키
앨런 롱
찰스 큐 멍
형익 이
Original Assignee
뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 filed Critical 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드
Priority to KR1020217043332A priority Critical patent/KR20220003663A/ko
Publication of KR20180100349A publication Critical patent/KR20180100349A/ko
Application granted granted Critical
Publication of KR102427124B1 publication Critical patent/KR102427124B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
KR1020187021726A 2015-12-28 2016-12-14 구충성 뎁시펩티드 화합물 Active KR102427124B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020217043332A KR20220003663A (ko) 2015-12-28 2016-12-14 구충성 뎁시펩티드 화합물

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562272040P 2015-12-28 2015-12-28
US62/272,040 2015-12-28
PCT/US2016/066497 WO2017116702A1 (en) 2015-12-28 2016-12-14 Anthelmintic depsipeptide compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020217043332A Division KR20220003663A (ko) 2015-12-28 2016-12-14 구충성 뎁시펩티드 화합물

Publications (2)

Publication Number Publication Date
KR20180100349A KR20180100349A (ko) 2018-09-10
KR102427124B1 true KR102427124B1 (ko) 2022-07-28

Family

ID=57868331

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020187021726A Active KR102427124B1 (ko) 2015-12-28 2016-12-14 구충성 뎁시펩티드 화합물
KR1020217043332A Abandoned KR20220003663A (ko) 2015-12-28 2016-12-14 구충성 뎁시펩티드 화합물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020217043332A Abandoned KR20220003663A (ko) 2015-12-28 2016-12-14 구충성 뎁시펩티드 화합물

Country Status (23)

Country Link
US (3) US10344056B2 (enExample)
EP (1) EP3397638B1 (enExample)
JP (1) JP6943859B2 (enExample)
KR (2) KR102427124B1 (enExample)
CN (1) CN108699052B (enExample)
AR (1) AR107249A1 (enExample)
AU (2) AU2016380868B2 (enExample)
BR (1) BR112018013369A2 (enExample)
CA (1) CA3009867C (enExample)
CL (1) CL2018001744A1 (enExample)
CO (1) CO2018006527A2 (enExample)
HK (1) HK1255391A1 (enExample)
HU (1) HUE065907T2 (enExample)
IL (1) IL260262B2 (enExample)
MX (1) MX2018007948A (enExample)
MY (1) MY194716A (enExample)
NZ (1) NZ743913A (enExample)
PH (1) PH12018501367B1 (enExample)
RU (2) RU2715556C2 (enExample)
SG (1) SG11201805368YA (enExample)
TW (1) TWI787165B (enExample)
UY (1) UY37050A (enExample)
WO (1) WO2017116702A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12018048B2 (en) 2015-12-28 2024-06-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE055535T2 (hu) * 2015-05-20 2021-12-28 Boehringer Ingelheim Animal Health Usa Inc Féreghajtó depszipeptid-vegyületek
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
JP2020504710A (ja) 2016-11-16 2020-02-13 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
PT3579696T (pt) 2017-02-08 2023-07-19 Boehringer Ingelheim Animal Health Usa Inc Modelo in vivo para infeção por vermes parasitários e métodos para avaliação de compostos antiparasíticos, que incluem compostos ativos contra a dirofilariose canina
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides
WO2019091975A1 (en) 2017-11-07 2019-05-16 Bayer Animal Health Gmbh Method for the synthesis of cyclic depsipeptides
NZ764359A (en) * 2017-11-29 2023-03-31 Zoetis Services Llc Endoparasitic depsipeptides
WO2019157241A1 (en) 2018-02-08 2019-08-15 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
AU2020205960B2 (en) 2019-01-10 2024-04-18 Zoetis Services Llc Anthelmintic laboratory animal model for heartworm
WO2020191091A1 (en) 2019-03-19 2020-09-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
EP4114358A4 (en) * 2020-03-06 2024-03-27 Lifemax Laboratories, Inc. TOPICAL PHARMACEUTICAL FORMULATIONS OF A CYCLIC DEPSIPEPTIDE
US11964977B2 (en) 2020-05-29 2024-04-23 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic heterocyclic compounds
US12161089B2 (en) 2020-12-21 2024-12-10 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal collar comprising isoxazoline compounds
US12258193B2 (en) 2022-02-17 2025-03-25 Boehringer Ingelheim Vetmedica Gmbh Method and system for providing a fluid product mailer
WO2025057117A1 (en) * 2023-09-15 2025-03-20 Animol Discovery, Inc. Antiparasitic cyclic depsipeptides

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO176766C (no) 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
NZ249588A (en) 1992-03-17 1996-08-27 Fujisawa Pharmaceutical Co Anthelmintic agent
AU695021B2 (en) 1993-02-19 1998-08-06 Meiji Seika Kaisha Ltd. PF1022 derivative cyclic depsipeptide
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317457A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
CN1061039C (zh) 1993-09-06 2001-01-24 藤泽药品工业株式会社 环状缩酚酸肽化合物或其盐及其制备方法和用途
SE9303657D0 (sv) 1993-11-05 1993-11-05 Astra Ab Short-acting dihydropyridines
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE4437198A1 (de) 1994-10-18 1996-04-25 Bayer Ag Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
DE19520275A1 (de) 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
NZ318515A (en) * 1995-09-22 2000-05-26 Bayer Ag Cyclodepsipeptide PF1022 derivatives and compositions thereof
US6235875B1 (en) 1996-10-07 2001-05-22 Fujisawa Pharmaceutical Co., Ltd. Process for producing depsipeptide derivatives and novel intermediates therefor
DE19713626A1 (de) 1997-04-02 1998-10-08 Bayer Ag Neue Thiodepsipeptide zur Bekämpfung von Endoparasiten und ein einfaches Verfahren zu ihrer Herstellung
BR9810412A (pt) 1997-06-04 2000-08-22 Bayer Ag Desoxiciclodepsipeptìdios e seu emprego para o combate de endoparasitas
DE19811559A1 (de) 1998-03-17 1999-09-23 Bayer Ag Cyclooctadepsipeptide
DE19828043A1 (de) 1998-06-24 1999-12-30 Bayer Ag Ektoparasitizide Mittel
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel
DE19962145A1 (de) 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel/Depsipeptide
DE19962147A1 (de) 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel / PF 1022-221
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10031044A1 (de) 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
DE10104362A1 (de) 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
UY26592A1 (es) 2001-02-20 2001-09-28 Bayer Ag Agentes endoparasiticidas
US6893652B2 (en) * 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
US20040236191A1 (en) 2003-05-19 2004-11-25 Poliska Steven A. System and method for identifying and labeling livestock products, and managing data associated with those products
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
ES2351972T3 (es) 2004-02-27 2011-02-14 Ic Services Procedimiento y set para la identificación de animales.
DE102004055316A1 (de) 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
US20060202835A1 (en) 2005-02-25 2006-09-14 Osborne Industries, Inc. Dual frequency identification device
DE102008022520A1 (de) 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
DE102008030764A1 (de) 2008-06-28 2009-12-31 Bayer Animal Health Gmbh Kombination von Amidin-Derivaten mit cyclischen Depsipeptiden
DE102008031284A1 (de) 2008-07-02 2010-01-07 Bayer Schering Pharma Aktiengesellschaft Neue Bekämpfungsmöglichkeit der Giardiose
DE102008031283A1 (de) 2008-07-02 2010-01-07 Bayer Schering Pharma Aktiengesellschaft Neue Bekämpfungsmöglichkeit von durch Trichomonadida hervorgerufenen Krankheiten
EP2379731A1 (de) 2008-12-16 2011-10-26 Bayer Animal Health GmbH Verfahren zur herstellung milchsäure- und phenylmilchsäurehaltiger optisch aktiver, cyclischer depsipeptide mit 24 ringatomen mit hilfe von pilzstämmen der art rosellinia sowie weiteren gattungen xylariaceen
KR101002530B1 (ko) 2009-02-18 2010-12-17 삼성에스디아이 주식회사 알에프아이디 통신 장치
US20120302496A1 (en) 2009-12-11 2012-11-29 Bayer Intellectual Property Gmbh Novel 24-membered cyclooctadepsipeptides from fungal strains and their use as anthelmintics or endoparasiticides
WO2012028556A1 (en) 2010-08-31 2012-03-08 Bayer Animal Health Gmbh Macrocyclic lactones and their use and their combinations with other active substances
WO2012065031A2 (en) 2010-11-11 2012-05-18 Mlp Technology Inc. Animal data management
US9848290B2 (en) 2011-03-10 2017-12-19 Aruba Networks, Inc. Location based computerized system and method thereof
MX356094B (es) 2011-12-21 2018-05-14 Bayer Ip Gmbh Preparaciones que comprenden emodepsido amorfo.
JP6300207B2 (ja) 2012-06-13 2018-03-28 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 新規環状デプシペプチド誘導体およびそれを含んでなる有害生物防除剤
US20140306005A1 (en) 2013-04-14 2014-10-16 Forever Yours, Inc. Method for Data Transport and Recovery of Dependent Creatures
HUE055535T2 (hu) * 2015-05-20 2021-12-28 Boehringer Ingelheim Animal Health Usa Inc Féreghajtó depszipeptid-vegyületek
CN108699052B (zh) 2015-12-28 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
JP2020504710A (ja) 2016-11-16 2020-02-13 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Bioorganic & Medicinal Chemistry Letters, Vol. 14, No. 24, pp. 6129-6132(2004.10.18.)
Bioorganic & Medicinal Chemistry Letters, Vol. 8, No. 9, pp. 1035-1040(1998.05.)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12018048B2 (en) 2015-12-28 2024-06-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds

Also Published As

Publication number Publication date
KR20180100349A (ko) 2018-09-10
PH12018501367B1 (en) 2022-10-21
TW201726670A (zh) 2017-08-01
JP2019504050A (ja) 2019-02-14
US11230571B2 (en) 2022-01-25
NZ743913A (en) 2019-04-26
UY37050A (es) 2017-07-31
AU2016380868A1 (en) 2018-07-19
US20170233438A1 (en) 2017-08-17
RU2018127195A3 (enExample) 2020-01-30
KR20220003663A (ko) 2022-01-10
IL260262A (en) 2018-07-31
SG11201805368YA (en) 2018-07-30
US12018048B2 (en) 2024-06-25
AU2020200854B2 (en) 2021-08-05
EP3397638B1 (en) 2023-08-23
CO2018006527A2 (es) 2018-07-10
TWI787165B (zh) 2022-12-21
BR112018013369A2 (pt) 2019-02-19
EP3397638A1 (en) 2018-11-07
US10344056B2 (en) 2019-07-09
HUE065907T2 (hu) 2024-06-28
RU2018127195A (ru) 2020-01-30
CN108699052A (zh) 2018-10-23
CA3009867A1 (en) 2017-07-06
US20220098241A1 (en) 2022-03-31
CL2018001744A1 (es) 2018-08-17
US20190248840A1 (en) 2019-08-15
CA3009867C (en) 2022-05-31
RU2020107484A (ru) 2020-03-19
AU2020200854A1 (en) 2020-02-27
MY194716A (en) 2022-12-15
PH12018501367A1 (en) 2019-02-27
CN108699052B (zh) 2022-04-29
AU2016380868B2 (en) 2019-11-28
HK1255391A1 (zh) 2019-08-16
IL260262B2 (en) 2023-06-01
WO2017116702A1 (en) 2017-07-06
JP6943859B2 (ja) 2021-10-06
RU2715556C2 (ru) 2020-03-02
AR107249A1 (es) 2018-04-11
MX2018007948A (es) 2018-08-01

Similar Documents

Publication Publication Date Title
KR102427124B1 (ko) 구충성 뎁시펩티드 화합물
JP7346675B2 (ja) 抗寄生虫性イソオキサゾリン化合物、それらを含む長時間作用性注射製剤、その方法及び使用
TWI693237B (zh) 驅蟲酯肽化合物
KR102785432B1 (ko) 구충성 헤테로시클릭 화합물
JP7637630B2 (ja) 駆虫性アザベンゾチオフェンおよびアザベンゾフラン化合物
EP3541789A1 (en) Anthelmintic depsipeptide compounds
RU2798093C2 (ru) Противогельминтные гетероциклические соединения

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20180726

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190109

Comment text: Request for Examination of Application

PN2301 Change of applicant

Patent event date: 20190920

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20200309

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20201026

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20200309

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20201026

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20200529

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20190109

Comment text: Amendment to Specification, etc.

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20201214

Patent event code: PE09021S01D

AMND Amendment
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210830

Patent event code: PE09021S01D

AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20211230

PX0701 Decision of registration after re-examination

Patent event date: 20220524

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20211230

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20210414

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20201126

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20201026

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20200529

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20190109

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220726

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220726

End annual number: 3

Start annual number: 1

PG1601 Publication of registration